There has been an issue of an alert of level one by the United States Centers for the Disease Control and Prevention (CDC) for Nigeria which is an African country.
The travel alert titled ‘Practice Usual Precautions’ was issued on the 21st of May 2019 because of the elevated risk to the exposure of the renowned ‘monkeypox’ virus.
In the month of April 2019, the health officials of Nigeria have reported around 300 plus cases of the viral monkeypox, which also includes numerous deaths as well. The rates of mortality have been reported to be up to 10% during the outbreak of this virus where the majority of the deaths took place in the younger segment of the population.
Earlier, in 2018, there were three foreign travelers who got this infection of Monkeypox in Nigeria who then returned to their respective homes in Israel and the United Kingdom. Also, there was another secondary case reported where the disease infected a healthcare worker who was in the United Kingdom.
In 2003, the United States of America also experienced an outbreak where 37 people are reported to have been infected with the monkeypox in 6 states of USA: Wisconsin, Indiana, Missouri, Illinois, Ohio, and Missouri, told the Center for Disease Control.
There was a possibility of human to human transmission but to a limited extent. The person who got infected during the period shows the symptom of a skin rash particularly.
Human-to-human transmission, while possible, is limited. A person is infectious only during the period when he has monkeypox symptoms, particularly a skin rash.
For the precaution, the person is preferred to be isolated either at home or put into any government isolation facility and he is monitored for around twenty-one days from the initial day of the exposure to the end of the case.
According to research, ACAM2000, which is a vaccine for the current smallpox is 85% effective in the prevention of this virus if given before the exposure to the virus.